STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
NVRO NEVRO CORPORATION StockScouter® Report
7
StockScouter® Score
NEVRO CORPORATION, a small cap value company in the healthcare sector, is expected to outperform the market over the next six months with slightly less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The enterprise value-to-sales ratio is much lower than the average for comparably-sized companies in the StockScouter universe. Very Positive
- The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
Concerns
- The multi-period measure of relative price change and consistency is well below average. Negative
- Moving average analysis for NVRO suggests weak price movement over the medium term. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, value stocks will be neutral, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
A
C
B
F